Allan Swift

Part of Siemens AG, In Vitro Diagnostics is a medical diagnostic testing American company. The company is located in the US. The company was founded in 1986. In Vitro Diagnostics was acquired by Dade Behring Holdings, Inc. from EIDP, Inc. on May 08, 1996 for $450 million.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom.

Platform Diagnostics Ltd. develops vitro diagnostics products. It develops POC diagnostic devices based on capillary agglutination technology, a reagent that combines with an analyte in blood and urine samples, and forms an agglutinate of molecules. The company was founded by Damian Bond in 2002 and is headquartered in Ossett, the United Kingdom.

Probe Scientific Ltd. develops medical devices. The firm offers MicroEye, ContinuMon and NanoEye products. The company was founded by Denis Lonergan and Mark O’Connell in 1998 and is headquartered in Thurleigh, the United Kingdom.